GNC Beyond Raw Rampant
Natural health product licensed in Canada
- Licence holder
- GNC Canada Holdings ULC
- NPN or DIN-HM
- 80040703
- Status
- Inactive licence
- Licence date
- 11 March 2013
- Revision date
- 14 March 2014
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Potassium: up to 80.004 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 80 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-phenylalanine | 8.334 mg | Not calculated |
| Acide bêta-aminopropionique | 116.667 mg | Not calculated |
| Acide (S)-2-amino-5-[(aminoiminométhyl)amino]pentanoïque | 308.334 mg | Not calculated |
| 1,3,7-Triméthylxanthine | 33.334 mg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 80 % Catechins | 8.334 mg | Not calculated |
| Acide aminoacétique | 8.334 mg | Not calculated |
| Trans-resvératrol Source : Synthétique | 25 mg | Not calculated |
| Trans-resvératrol Source : Reynoutria Japonica - racine | 25 mg | Not calculated |
| Glycine, N-(aminoiminomethyl) | 8.334 mg | Not calculated |
| Potassium Source : Chlorure de potassium | 13.334 mg | 80,004 µg |
| 3,3'-dihydroxy-4,4'-diketo-bêta-carotène Source : Haematococcus pluvialis - whole | 8.334 mcg | Not calculated |
| Calcium Source : Phosphate de calcium, dibasique | 25 mg | 150,000 µg |
| 2-hydroxy-N,N,N-triméthyléthanaminium Source : Bitartrate de choline | 1.667 mg | Not calculated |
| Alpha-cétoglutarate de calcium | 8.334 mg | Not calculated |
Non-medicinal ingredients
Acide oléique, Acide stéarique, Chlorure de sodium, Alcool isopropylique, Ethylcellulose, Poly(éthylène glycol), Triacétine, Acetylated Monoglycerides, Croscarmellose de sodium, Microcrystalline cellulose, Crospovidone, Éthanol, Calcium Silicate, Cire de Carnauba, Stéarate de magnésium, Hydroxypropylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 6 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
L-Arginine is a non-essential amino acid that is involved in protein synthesis. A factor in the maintenance of good health. Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Used (temporarily) as a mild diuretic. Source of antioxidants for the maintenance of good health. Provides antioxidants for the maintenance of good health. Helps the body to metabolize carbohydrates. Helps the body to metabolize fats. Helps the body to metabolize proteins. Helps normal growth and development.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80040703
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging